Recent Finacing
Recent Raise
ReviR Therapeutics develops AI-driven small-molecule RNA-targeting therapies via the VoyageR platform to discover and optimize splice-modulating compounds for Huntington’s, CMT, ALS, and other rare neurological disorders.
